featured
Risankizumab vs Ustekinumab for Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risankizumab Versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
N. Engl. J. Med 2017 Apr 20;376(16)1551-1560, KA Papp, A Blauvelt, M Bukhalo, M Gooderham, JG Krueger, JP Lacour, A Menter, S Philipp, H Sofen, S Tyring, BR Berner, S Visvanathan, C Pamulapati, N Bennett, M Flack, P Scholl, SJ PadulaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.